ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals Inc (ATNM)

1,50
0,04
(2,74%)
1,56
0,06
(4,00%)
Après les heures de négociation: 1:05AM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
1,56
Prix Achat
-
Prix Vente
-
Volume échangé
238 731
1,43 Fourchette du Jour 1,57
1,0292 Plage de 52 semaines 8,64
Cap du marché
Clôture Veille
1,46
Ouverture
1,47
Dernière Transaction
16534
@
1.5
Dernière heure de transaction
Volume financier
US$ 353 574
VWAP
1,4811
Volume moyen (3 m)
317 586
Actions en circulation
31 195 891
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,21
Bénéfice par action (BPA)
-1,23
Chiffre d'affairess
-
Bénéfice net
-38,24M

À propos de Actinium Pharmaceuticals Inc

Actinium develops Antibody Radiation Conjugates ('ARCs') and other targeted radiotherapies intended to meaningfully improve outcomes for people who have failed existing oncology therapies. Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and re... Actinium develops Antibody Radiation Conjugates ('ARCs') and other targeted radiotherapies intended to meaningfully improve outcomes for people who have failed existing oncology therapies. Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia ('r/r AML'), which Actinium plans to advance with a potential strategic partner in the U.S. following completion of FDA interactions. The company continues to advance its development for product candidate Actimab-A, a therapeutic agent that has demonstrated potential activity in r/r AML patients. In addition, Actinium is engaged with the National Cancer Institute ('NCI') under the Cooperative Research and Development Agreement ('CRADA') for development of Actimab-A in AML and other myeloid malignancies. Show more

Secteur
Blank Checks
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
1997
Actinium Pharmaceuticals Inc est coté dans le secteur Blank Checks de la American Stock Exchange avec le ticker ATNM. Le dernier cours de clôture d'Actinium Pharmaceuticals était de US$1,46. Au cours de la dernière année, les actions de Actinium Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 1,0292 à US$ 8,64.

Actinium Pharmaceuticals compte actuellement 31 195 891 actions en circulation. La capitalisation boursière d'Actinium Pharmaceuticals est de US$45,55 million. Actinium Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -1.21.

ATNM Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.02-1.265822784811.581.6151.412759261.47991085CS
4-0.09-5.454545454551.651.94541.412404461.64921305CS
12-0.4-20.40816326531.961.981.133175861.49695339CS
260.4236.84210526321.142.411.02924462971.55267605CS
52-6.31-80.17789072437.878.641.02924918762.21929512CS
156-3.77-70.73170731715.3315.121.02923529295.85360721CS
2601.1685298.467432950.391515.120.2859460032.73090844CS

ATNM - Frequently Asked Questions (FAQ)

What is the current Actinium Pharmaceuticals share price?
The current share price of Actinium Pharmaceuticals is US$ 1,56
How many Actinium Pharmaceuticals shares are in issue?
Actinium Pharmaceuticals has 31 195 891 shares in issue
What is the market cap of Actinium Pharmaceuticals?
The market capitalisation of Actinium Pharmaceuticals is USD 45,55M
What is the 1 year trading range for Actinium Pharmaceuticals share price?
Actinium Pharmaceuticals has traded in the range of US$ 1,0292 to US$ 8,64 during the past year
What is the PE ratio of Actinium Pharmaceuticals?
The price to earnings ratio of Actinium Pharmaceuticals is -1,21
What is the reporting currency for Actinium Pharmaceuticals?
Actinium Pharmaceuticals reports financial results in USD
What is the latest annual profit for Actinium Pharmaceuticals?
The latest annual profit of Actinium Pharmaceuticals is USD -38,24M
What is the registered address of Actinium Pharmaceuticals?
The registered address for Actinium Pharmaceuticals is 108 W. 13TH STREET SUITE 100, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Actinium Pharmaceuticals website address?
The website address for Actinium Pharmaceuticals is www.actiniumpharma.com
Which industry sector does Actinium Pharmaceuticals operate in?
Actinium Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MITQMoving iMage Technologies Inc
US$ 0,82
(48,26%)
190,65M
SYNXSilynxcom Ltd
US$ 2,07
(21,76%)
818,13k
GNSGenius Group Limited
US$ 0,543001
(21,21%)
66,94M
MPUMega Matrix Inc
US$ 1,07
(20,22%)
711,94k
VNRXVolitionRX Limited
US$ 0,80416
(19,81%)
958,89k
HUSAHouston American Energy Corp
US$ 14,85
(-15,14%)
2,13M
RYDERyde Group Ltd
US$ 0,388
(-13,78%)
11,7M
MXCMexco Energy Corp
US$ 11,3961
(-13,07%)
35,33k
RODEHartford Multifactor Diversified International ETF
US$ 27,57
(-12,81%)
218
CVRChicago Rivet and Machine Co
US$ 11,8801
(-12,00%)
3,73k
MITQMoving iMage Technologies Inc
US$ 0,82
(48,26%)
190,7M
DNNDenison Mines Corp
US$ 1,73
(-5,98%)
171,46M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 21,21
(-1,85%)
137,08M
SOXSDirexion Daily Semiconductor Bear 3X Shares New
US$ 9,54
(2,03%)
133,55M
SPYSPDR S&P 500
US$ 594,28
(-0,53%)
94,05M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock